Weighted Average Number of Shares Outstanding, Diluted of PAVmed Inc. from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
PAVmed Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • PAVmed Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 21,554,546, a 52% decline year-over-year.
  • PAVmed Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 65,291,623, a 803% increase from 2023.
  • PAVmed Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 7,231,546, a 22% increase from 2022.
  • PAVmed Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 5,938,406.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

PAVmed Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 21,554,546 -22,921,092 -52% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 18,084,653 +8,931,834 +98% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 52,496,401 +43,801,497 +504% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 65,291,623 +58,060,077 +803% 01 Oct 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q3 2024 44,475,638 +37,012,887 +496% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 9,152,819 +2,196,164 +32% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 8,694,904 +2,221,894 +34% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 7,231,546 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 7,462,751 -82,296,176 -92% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 6,956,655 -80,000,697 -92% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 6,473,010 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q3 2022 89,758,927 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 86,957,352 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q4 2016 12,972,153 +1,693,398 +15% 01 Oct 2016 31 Dec 2016 10-K 16 Feb 2017 2016 FY
Q3 2016 13,310,000 +2,171,495 +19% 01 Jul 2016 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 12,995,495 +2,139,124 +20% 01 Apr 2016 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 12,250,000 +1,393,629 +13% 01 Jan 2016 31 Mar 2016 10-Q/A 20 May 2016 2016 Q1
Q4 2015 11,278,755 01 Oct 2015 31 Dec 2015 10-K 16 Feb 2017 2016 FY
Q3 2015 11,138,505 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 10,856,371 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016 2016 Q2
Q1 2015 10,856,371 01 Jan 2015 31 Mar 2015 10-Q/A 20 May 2016 2016 Q1

PAVmed Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 65,291,623 +58,060,077 +803% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
2023 7,231,546 +1,293,140 +22% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 5,938,406 01 Jan 2022 31 Dec 2022 10-K 25 Mar 2024 2023 FY
2016 12,972,153 +1,693,398 +15% 01 Jan 2016 31 Dec 2016 10-K 16 Feb 2017 2016 FY
2015 11,278,755 01 Jan 2015 31 Dec 2015 10-K 16 Feb 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.